Observational study of dronedarone in Taiwanese patients with atrial fibrillation
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
119
Journal Issue
1 Pt 1
Pages
59-68
Date Issued
2020-01
Author(s)
Wu, Tsu-Juey
Chen, Ching-Pei
Hsu, Jung-Cheng
Ueng, Kwo-Chang
Kuo, Jen-Yuan
Chen, Mien-Cheng
Yeh, Kuan-Hung
Chang, Kuan-Cheng
Lu, Yen-Yu
Shyu, Kou-Gi
Wen, Ming-Shien
Chen, Shih-Ann
Hsieh, Ming-Hsiung
Tseng, Wei-Kung
Feng, An-Ning
Yang, Teng-Yao
Ko, Wen-Chin
Cheng, Chi-Wen
Liu, Ju-Chi
Lai, Wen-Ter
Abstract
Currently, data on the real-world use of dronedarone, an antiarrhythmic drug for atrial fibrillation (AF), are contradictory and often based on patient populations comprised of Caucasians. We prospectively investigated the efficacy and safety of dronedarone and risk factors related to treatment outcomes in a real-world use setting.
Subjects
Atrial fibrillation; Dronedarone; Observational; Quality of life; Safety
Type
journal article